Abdul Mannan: What’s Your Approach When JAK2 Shows Up in Unusual Thrombosis?
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn:
”You find JAK2V617F in a patient with splanchnic vein thrombosis.
Counts are normal. The marrow doesn’t show MPN.
Now what?
Here’s the thing: JAK2 positivity in SVT means clonal, persistent risk. It doesn’t disappear just because the blood count looks normal.
Here’s what the evidence tells us:
• JAK2+ SVT behaves as a chronic prothrombotic state, even without overt MPN on counts or marrow
• Budd-Chiari syndrome should get indefinite anticoagulation from the start (target INR 2-3 with LMWH or VKA )
• Portal or mesenteric vein thrombosis with JAK2 positivity usually needs extended or indefinite anticoagulation, tailored to bleeding risk
• Ruxolitinib (Jakavi) is NOT standard for thrombosis prevention alone – it may help if an overt MPN later declares itself, but it doesn’t replace anticoagulation
• Cytoreduction isn’t indicated when counts are truly normal
Here’s what matters for follow-up: some patients do progress to overt MPN over time
. One cohort had 30% declare MPN at a median of 41 months.
So you’re looking at periodic CBCs, iron studies if polycythemia concerns you, and keeping step with hepatology for varices and bleeding risk.
The lesson for clinic: don’t withhold anticoagulation waiting for “diagnostic” marrow features, and don’t reach for ruxolitinib to avoid anticoagulation.
Both are misses.
What’s your approach when JAK2 shows up in unusual thrombosis?”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome